The NEURO-TTRansform trial (NCT01737398), an open-label, single-group, phase 3 study, investigated Eplontersen in adults with ATTRv polyneuropathy, NIS 10-130, and a documented TTR variant [13]. Here, TTR is linked to polyneuropathy.